Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-07

Clinical Trial Update: Cysteamine Compared to Hydroquinone in Melasma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing cysteamine to hydroquinone in the treatment of melasma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cysteamine (cysteamine)
  • Hydroquinone (hydroquinone)

Snippet

Sponsor: China Medical University Hospital | Conditions: Melasma | Phase 3 | Status: COMPLETED